com Notes to the financial statements continued 158 25.
Cash and cash equivalents and non-cash transactions Own shares 2011 2010 US$m Cash at bank and in hand 945 733 Short-term deposits 1,003 989 1,948 1,722 The majority of cash at bank and in hand earns interest at floating rates of interest with a limited amount at fixed rates of interest or interest-free.
Short-term deposits are made at call and for less than one week, dependent on the short-term cash requirements of the Group, and earn interest based on the respective short-term deposit rates.
The fair value of cash and cash equivalents at 31 December 2011 and 31 December 2010 approximates carrying value.
For the purposes of the consolidated cash flow statement, cash and cash equivalents comprise the following at 31 December: 2011 2010 US$m Cash at bank and in hand 945 733 Short-term deposits 1,003 989 Bank overdrafts refer to note 28 5 12 1,943 1,710 During the year, the Group entered into new finance leases and hire purchase contracts to purchase various items of plant and equipment for US$5 million 2010 US$68 million which did not require the use of cash and cash equivalents and are not included in the net cash flow used in investing and financing activities in the consolidated cash flow statement.
Capital and reserves US$m Authorised: Consolidated changes in equity Other reserves 4,500,000,000 ordinary shares of US$0.50 each as at 1 January 2010, 31 December 2010 and 31 December 2011 2,250 50,000 deferred shares of GBP1.00 each as at 1 January 2010, 31 December 2010 and at 31 December 2011 1 special voting share of US$0.50 as at 1 January 2010, 31 December 2010 and as at 31 December 2011 2,250 Issued, called up and fully paid: 2,939,011,620 ordinary shares of US$0.50 each as at 1 January 2010 1,469 25,680,456 ordinary shares issued on the exercise of convertible borrowings 13 2,964,692,076 ordinary shares of US$0.50 each as at 31 December 2010 and 31 December 2011 1 1,482 Share premium: As at 1 January 2010 15,096 25,680,456 ordinary shares issued on the exercise of convertible borrowings 362 As at 31 December 2010 and as at 31 December 2011 15,458 US$m Own shares: 40,626,878 ordinary shares of US$0.50 each as at 1 January 2010 1,306 1,440 1,229 159 3,853 6,681 5,832,841 ordinary shares disposed during the year 136 521,098 ordinary shares purchased during the year 11 35,315,135 ordinary shares of US$0.50 each as at 31 December 2010 1,181 Revaluation reserves 2,635,979 ordinary shares disposed during the year 59 777,678 ordinary shares purchased during the year 18 Other reserves 33,456,834 ordinary shares of US$0.50 each as at 31 December 2011 1,140 Details in respect of the various classes of shares are outlined in the Directors Report on page 112.
Ordinary shares Net unrealised gains losses reserve During 2010, the US$375 million convertible borrowings were converted at the option of the holders into 25,680,456 ordinary shares in Xstrata plc.
Strategic review Performance review Governance Financial statements | Xstrata | Annual Report 2011 | www.
Cash and cash equivalents and non-cash transactions Own shares 159 Own shares comprise shares of Xstrata plc held in the ESOP and shares held by Batiss Investments Batiss for the ECMP.
2011 945 The shares acquired by the ESOP are either stock market purchases or share issues from the Company.
The ESOP is used to co-ordinate the funding and 1,003 manages the delivery of ordinary shares for options and free share awards under the Groups employee award schemes.
The trustee of the ESOP is permitted to place the shares back into the market and may hold up to 5% of the issued share capital of the Company at any one time.
At 31 December 2011, 5,028,048 1,948 2010: 6,886,349 shares, equivalent to 0.2% 2010: 0.2% of the total issued share capital, were held by the trust with a cost of US$114 million 2010 US$155 million and market value of US$76 million 2010 US$162 million.
The trust has waived the right to receive dividends from the shares that it holds.
Costs relating to the administration of the trust are expensed in the period in which they are incurred.
The shares acquired from the stock market by Batiss and held for the ECMP are used by the Group as a source of financing for future acquisitions, or placed back into the market.
The decision as to when to place the shares in the market, use the shares to assist the Group in facilitating future transactions, or to repurchase shares for cancellation, is considered in light of the Groups funding requirements and capital structure.
2011 Batiss is not permitted to hold more than 10% of the issued share capital of the Company at any one time.
Batiss has entered into an option agreement with 945 Xstrata Finance Dubai Limited Xstrata Finance, a wholly-owned subsidiary within the Xstrata Group, whereby Batiss has granted to Xstrata Finance a right to 1,003 require Batiss to sell the purchased Xstrata shares to a third party other than a subsidiary of Xstrata plc, as nominated by Xstrata Finance, at an exercise price 5 of 1p per share.
Under the option agreement, Xstrata Finance pays Batiss a premium for this right, the premium being the equivalent of the market price paid 1,943 by Batiss for the shares plus associated costs less the 1p exercise price.
This premium payment, together with funds from a subscription by Xstrata Finance for non-voting redeemable preference shares in Batiss, provides the funding for Batiss to acquire the shares in the market.
These payments are sourced from the existing and future cash resources of Xstrata Finance.
Xstrata Finance is able to exercise its right under the option agreement for a period of six years from the date of each purchase, but has not chosen to do so in either 2011 or 2010.
Batiss has waived its right to receive dividends on the shares that it holds.
At 31 December 2011, 28,428,786 2010: 28,428,786 shares, equivalent to 1.0% 2010: 1.0% of the total issued share capital, were held by the trust with a cost of US$1,026 million 2010 US$1,026 million and market value of US$432 26.
Capital and reserves million 2010 US$668 million.
Consolidated changes in equity Other reserves Foreign Revaluation Net unrealised currency reserves Other reserves gains losses translation Total US$m At 31 December 2009 1,440 1,229 188 2,749 5,606 Gains on available-for-sale financial assets 118 118 Realised losses on available-for-sale financial assets 73 73 Gains on cash flow hedges 117 117 1,482 Realised gains on cash flow hedges 131 131 Foreign currency translation differences 2,459 2,459 Deferred tax 9 48 57 At 31 December 2010 1,440 1,229 210 5,160 8,039 Unrealised losses on available-for-sale financial assets 37 37 15,458 Realised gains on available-for-sale financial assets 8 8 Gains on cash flow hedges 26 26 Realised gains on cash flow hedges 51 51 Foreign currency translation differences 1,309 1,309 Deferred tax 19 2 21 At 31 December 2011 1 1,440 1,229 159 3,853 6,681 Recycled gains of US$59 million 2010 US$115 million are included in Revenue in the income statement, including non-controlling interests.
Revaluation reserves This reserve principally records the re-measurement from cost of the 19.9% interest held in Falconbridge Limited Falconbridge to the fair value of 19.9% of the identifiable net assets of Falconbridge on 15 August 2006, the date the Group obtained control of Falconbridge.
Other reserves 1,140 This reserve principally originated during 2002 from the merger of Xstrata AG into Xstrata plc of US$279 million and the issue of shares from the acquisition of the Duiker and Enex Groups of US$935 million.
Ordinary shares Net unrealised gains losses reserve This reserve records the re-measurement of available-for-sale financial assets to fair value refer to note 22 and the effective portion of the gain or loss on cash flow hedging contracts refer to notes 23, 29 and 36.
Deferred tax is provided on the re-measurement at tax rates enacted or substantively enacted.
